Monitoring of human cytomegalovirus and virus-specific T-cell response in young patients receiving allogeneic hematopoietic stem cell transplantation.
In allogeneic hematopoietic stem-cell transplantation (HSCT) recipients, outcome of human cytomegalovirus (HCMV) infection results from balance between viral load/replication and pathogen-specific T-cell response. Using a cut-off of 30,000 HCMV DNA copies/ml blood for pre-emptive therapy and cut-off...
Saved in:
Main Authors: | Daniele Lilleri, Giuseppe Gerna, Paola Zelini, Antonella Chiesa, Vanina Rognoni, Angela Mastronuzzi, Giovanna Giorgiani, Marco Zecca, Franco Locatelli |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2012
|
Subjects: | |
Online Access: | https://doaj.org/article/77a56ab237794f48bd4b18e32b10a1f1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hepatitis B Virus Infection in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation
by: Yi-Chang Liu, et al.
Published: (2021) -
Human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells are both required for prevention of HCMV disease in seropositive solid-organ transplant recipients.
by: Elisa Gabanti, et al.
Published: (2014) -
A Model of Minor Histocompatibility Antigens in Allogeneic Hematopoietic Cell Transplantation
by: Paul J. Martin, et al.
Published: (2021) -
T-cell receptor repertoire of cytomegalovirus-specific cytotoxic T-cells after allogeneic stem cell transplantation
by: Takashi Toya, et al.
Published: (2020) -
Variable selection methods for predicting clinical outcomes following allogeneic hematopoietic cell transplantation
by: Chloé Pasin, et al.
Published: (2021)